Detalhe da pesquisa
1.
Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial.
J Autism Dev Disord
; 54(3): 894-904, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626004
2.
Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder.
Biol Psychiatry Cogn Neurosci Neuroimaging
; 8(3): 251-261, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506972
3.
Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial.
Front Psychiatry
; 13: 780281, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35211042
4.
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study.
Front Neurosci
; 16: 879451, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35645706
5.
Dr. Sprengers et al. Reply.
J Am Acad Child Adolesc Psychiatry
; 60(8): 938-939, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450401
6.
The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder.
J Patient Rep Outcomes
; 5(1): 123, 2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34787751
7.
Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.
J Am Acad Child Adolesc Psychiatry
; 60(7): 865-876, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730977
8.
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
Mol Autism
; 11(1): 30, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381101